Recent abolon transactions

EQUITA acquires a majority in Windstar Medical

In November 2014, EQUITA Management has, alongside management, acquired a majority stake in Windstar Medical

Read more

Healthcare insights

Handelsblatt Publishing Group: The Generics Fascination

During the last decade, the generics industry has changed at a rate not observed in any other segment of the healthcare sector

Read more

Healthcare deal of the month

November 2014: Siegfried acquires Hameln Pharma

The Deal: In November 2014, Siegfried Group acquires Hameln Pharma in Germany, consisting of Hameln Pharmaceuticals GmbH and Hameln RDS GmbH. Hameln Pharma engages in the development and production

Read more


Abolon is a strategy consulting and corporate finance company with an exclusive focus on the healthcare sector.

We pride ourselves on our specialist insights into the various segments of the healthcare markets in Europe and beyond.

Our global network in the healthcare sector provides us with unmatched dealflow of large and mid-sized healthcare opportunities.

Facts & figures

  • Healthcare forms an enormous ...
  • Stable healthcare sector attracts ...
  • The global pharmaceutical market ...
  • The healthcare sector offers ...
  • Abolon has advised on ...
  • Healthcare forms an enormous part of developed country's economy, contributing over 10 percent of gross domestic product (GDP).
  • Stable healthcare sector attracts record private equity investments.
  • The global pharmaceutical market is expected to grow from 995 $bn in 2011 to 1160 $bn in 2016
  • The healthcare sector offers numerous opportunities at low risk
  • Abolon has advised on 4 successful healthcare transactions in the last 18 months.